Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

9.5%

2 terminated/withdrawn out of 21 trials

Success Rate

84.6%

-1.9% vs industry average

Late-Stage Pipeline

24%

5 trials in Phase 3/4

Results Transparency

0%

0 of 11 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
7(46.7%)
Phase 3
4(26.7%)
Phase 2
3(20.0%)
Phase 4
1(6.7%)
15Total
N/A(7)
Phase 3(4)
Phase 2(3)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (21)

Showing 20 of 21 trials
NCT03915366Phase 2Completed

Empirical Treatment Against Cytomegalovirus and Tuberculosis in HIV-infected Infants With Severe Pneumonia

Role: collaborator

NCT04078997Completed

An Evaluation of PCV13 Vaccine Schedules, Comparing Impact of 2+1 vs 3+0 on Pneumococcal Carriage in Blantyre, Malawi

Role: collaborator

NCT03299426Phase 3Active Not Recruiting

Clinical Efficacy of Typhoid Conjugate Vaccine (Vi-TCV) Among Children Age 9 Months Through 12 Years in Blantyre, Malawi

Role: collaborator

NCT05452616Not ApplicableCompleted

Same-day Versus Rapid ART Initiation in HIV-positive Individuals Presenting With Symptoms of Tuberculosis

Role: collaborator

NCT04190303Completed

BIGlobal Intervention Study: Improving Diagnosis and Management of Suspected Brain Infections Globally

Role: collaborator

NCT06047821Active Not Recruiting

Enterics for Global Health (EFGH)

Role: collaborator

NCT06312072Unknown

Understanding Risk Factors for Progressive Chronic Kidney Disease in Malawi

Role: collaborator

NCT06178666Not ApplicableNot Yet Recruiting

A Controlled Human Infection Model (CHIM) With Intradermal BCG in Malawi

Role: collaborator

NCT05137210Not ApplicableUnknown

Identifying Efficient Linkage Strategies for Men

Role: collaborator

NCT04545164Not ApplicableCompleted

Computer Aided Screening for Tuberculosis in Low Resource Environments

Role: collaborator

NCT03208179Phase 3Completed

Improving PRegnancy Outcomes With Intermittent preVEntive Treatment in Africa

Role: collaborator

NCT04089423Completed

FujiLAM Prospective Evaluation Trial

Role: collaborator

NCT04285905Phase 2Terminated

Male Partner-assisted Contact Tracing for HIV and Tuberculosis in Malawi

Role: collaborator

NCT03541382Not ApplicableCompleted

A Cluster Randomised Trial of Community-led Distribution of HIV Self-tests in Rural Malawi (HIV Self-Testing Africa [STAR])

Role: collaborator

NCT03130114Phase 3Completed

Antibiotics for Children With Severe Diarrhoea

Role: collaborator

NCT03519425Not ApplicableUnknown

A Pragmatic Randomised Study to Optimise Screening, Prevention and Care for Tuberculosis in Malawi

Role: collaborator

NCT02426112Phase 3Completed

Bronchopulmonary Function in Response to Azithromycin Treatment for Chronic Lung Disease in HIV-infected Children

Role: collaborator

NCT03341767Phase 2Terminated

A Phase 2A Evaluation of the Safety, Tolerability, Pharmacokinetics, Efficacy of Clofazimine (CFZ) in Cryptosporidiosis

Role: collaborator

NCT02718274Not ApplicableCompleted

HIV Self-Testing Africa (STAR) Malawi: General Population

Role: collaborator

NCT02779907Unknown

Prevalence and Associations of Paediatric Chronic Suppurative Otitis Media and Hearing Impairment in Rural Malawi

Role: collaborator